Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
863 2 |
Ultima descărcare din IBN: 2021-07-21 23:07 |
SM ISO690:2012 ŞCIUCA, Svetlana. Aprecierea clinică a medicaţiei mucolitice cu Flavamed la copiii cu maladii bronhopulmonare cronice
. In: Curierul Medical, 2009, nr. 2 (308), pp. 6-7. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | |||||
Numărul 2 (308) / 2009 / ISSN 1875-0666 | |||||
|
|||||
Pag. 6-7 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Clinical Evaluation of Mucolytic Therapy with Flavamed for Children with Chronic Bronchopulmonary Diseases
The study showed clinical effectiveness of Flavamed (Ambroxol) in the treatment of children with bronchopulmonary diseases in various forms
and it is recommended for patients with chronic bronchitis and cystic fibrosis. In mucoviscidosis with bronchopulmonary affectation treatement
with mucolitic medication is successful in the reestablishment of the permeability of the bronchial tree. Because of the superiority of Ambroxol
to other secretolitic and expectorant drugs it can be used in the continuing of children with mucoviscidosis during the rehabilitation period.
|
|||||
Cuvinte-cheie Flavamed, bronhopulmonary disease |
|||||
|